Clinical Guide

Herniated Disc
Symptoms.

9/10 Oswestry disability domains improved (p<0.001). SSEP latency normalized (p=0.016–0.022). The complete guide to disc herniation recognition, diagnosis grading, and the PEMF protocol for Philippine clinic operators.

← Back to Articles
Clinical assessment for herniated disc symptoms and PEMF treatment

What Is a Herniated Disc?

The intervertebral disc is a fibrocartilaginous structure consisting of a tough outer annulus fibrosus surrounding a gelatinous nucleus pulposus. When repeated mechanical loading, acute trauma, or degenerative change causes fissuring of the annulus, the nucleus can protrude (bulge), extrude, or fully sequester into the spinal canal. This progression — from bulge to full herniation — produces the clinical picture that clinicians and investors need to understand: a patient population that is large, treatment-seeking, and poorly served by pharmacological options alone.

Disc herniation affects approximately 5–20 per 1,000 adults annually, with peak incidence between ages 30–50 years. Lumbar disc herniation accounts for roughly 90% of all cases; L4–L5 and L5–S1 account for 95% of lumbar herniations. Cervical herniation, most common at C5–C6 and C6–C7, presents a distinct symptom profile with upper extremity involvement.

Symptom Classification by Herniation Stage

Understanding symptom patterns by herniation grade is essential for clinical triage and appropriate PEMF protocol selection.

Stage Pathology Typical Symptoms PEMF Applicability
Disc Bulge (Grade I) Annulus intact; nucleus displaced posteriorly Diffuse low back or neck ache; pain with flexion; no radicular symptoms High — primary intervention
Protrusion (Grade II) Annulus partly torn; nucleus protrudes but contained Localized radicular pain; intermittent paraesthesia in dermatome; positive SLR High — adjunct to manual therapy
Extrusion (Grade III) Nucleus breaches annulus; ligament intact Continuous radicular pain; sensory deficit; reflex asymmetry; SSEP latency changes Moderate — combination with epidural consult
Sequestration (Grade IV) Fragment free in canal Severe neurological deficit; motor weakness; possible cauda equina signs Surgical evaluation first; PEMF adjunct post-decompression

Lumbar Herniation: Key Symptom Patterns

L3–L4 Disc Herniation

Affects the L4 nerve root. Symptoms: anterior thigh pain radiating to medial leg, weakness in knee extension, reduced patellar reflex, sensory loss medial shin. This pattern is frequently misdiagnosed as femoral neuropathy or hip pathology.

L4–L5 Disc Herniation (Most Common)

Affects the L5 nerve root. Symptoms: pain from low back through buttock, posterior thigh, lateral calf to dorsum of foot; weakness in great toe extension (extensor hallucis longus); sensory loss dorsal foot. The straight leg raise (SLR) test is positive at 30–60° with radicular reproduction (sensitivity 80%, specificity 40%).

L5–S1 Disc Herniation (Second Most Common)

Affects the S1 nerve root. Symptoms: pain posterior thigh to lateral foot and fifth toe; weakness in plantarflexion; absent or reduced Achilles reflex; sensory loss lateral foot. Calf weakness and reflex asymmetry are the defining neurological signs.

Cervical Herniation: Key Symptom Patterns

C5–C6 Disc Herniation

Affects the C6 nerve root. Symptoms: neck and shoulder pain radiating to lateral forearm and thumb/index finger; weakness in biceps and wrist extensors; reduced biceps reflex. Often presents as persistent shoulder pain misattributed to rotator cuff pathology.

C6–C7 Disc Herniation

Affects the C7 nerve root. Symptoms: posterior arm pain to middle finger; weakness in triceps and wrist flexors; reduced triceps reflex. Grip weakness is a common functional complaint, causing significant occupational impairment in the BPO and manufacturing workforce.

Electrodiagnostic Evidence: SSEP as an Objective Outcome Marker

Somatosensory evoked potential (SSEP) testing provides objective neurophysiological evidence of radiculopathy severity and treatment response. A randomized controlled trial (PMID 23083041, n=40, lumbar radiculopathy from disc herniation) demonstrated that PEMF treatment produced statistically significant normalization of SSEP parameters:

  • SSEP latency: bilateral improvement, p=0.016 (left), p=0.022 (right)
  • SSEP amplitude: bilateral improvement, p=0.001 (left), p=0.002 (right)
  • VAS pain score: significant reduction, p=0.024
  • Oswestry Disability Index: improvement in 9 of 10 domains (total OSW p<0.001)

SSEP normalization is particularly important for clinic operators: it provides objective documentation of nerve root recovery that supplements patient-reported outcomes — a key differentiator when positioning PEMF for insurer or employer reimbursement conversations.

Clinical Red Flags That Require Immediate Referral

Not all disc herniation patients are appropriate for conservative treatment without surgical consultation. Identify these absolute red flags before initiating PEMF:

  • Cauda equina syndrome: bilateral leg weakness, saddle anaesthesia, bowel or bladder dysfunction — surgical emergency
  • Progressive motor deficit: worsening foot drop or hand weakness over days
  • Fever with back pain: exclude spinal infection (discitis, epidural abscess)
  • History of cancer: exclude spinal metastasis before attributing to disc pathology
  • Fracture risk: osteoporosis + trauma + acute onset — imaging first

Diagnostic Pathway for Clinic Operators

  1. History: onset, character (sharp/burning/aching), radiation pattern, aggravating/relieving factors, neurological symptoms
  2. Physical examination: SLR (lumbar), Spurling's test (cervical), neurological screening (reflexes, myotomes, dermatomes)
  3. Imaging review: MRI is gold standard — correlate clinical symptoms with disc level; note that 30% of asymptomatic adults have MRI-visible disc bulges
  4. Neurophysiology (if available): SSEP and EMG/NCS for objective radiculopathy grading and treatment monitoring
  5. PEMF eligibility: Grade I–III without red flags; Grade IV post-surgical clearance

PEMF Mechanism in Disc Herniation

Four evidence-based pathways underlie PEMF's effect on the herniated disc pain complex:

  1. Anti-inflammatory action on the compressed nerve root: reduction of TNF-α and IL-1β in the epidural space reduces chemical irritation of the nerve root — a major contributor to radicular pain independent of mechanical compression.
  2. Microcirculation improvement in periradicular tissue: pulsed fields increase nitric oxide (NO) production, improving capillary perfusion in the compressed nerve root territory and reducing ischaemic pain.
  3. Modulation of nociceptive signalling: membrane stabilization of A-δ and C nerve fibers raises the pain threshold in sensitized radicular pathways.
  4. Intervertebral disc biology: emerging 2026 data (Frontiers in Aging, doi:10.3389/fragi.2026.1840672) indicates PEMF activates SIRT1-autophagy pathways in nucleus pulposus cells, promoting extracellular matrix restoration and reducing degenerative acceleration — a compelling structural argument beyond symptomatic relief.

PEMF Protocol by Disc Level

Level Frequency Intensity Coil Placement Session Duration Course Length
L3–L4 10–25 Hz 40–80 Gauss Lumbar + anterior thigh pad 30 min 8–12 sessions
L4–L5 10–25 Hz 40–80 Gauss Lumbar + posterolateral leg 30–40 min 8–12 sessions
L5–S1 10–25 Hz 40–80 Gauss Lumbosacral + posterior calf 30–40 min 8–12 sessions
C5–C6 15–30 Hz 30–60 Gauss Cervical + shoulder/lateral forearm 25–30 min 6–10 sessions
C6–C7 15–30 Hz 30–60 Gauss Cervical + posterior arm/forearm 25–30 min 6–10 sessions

What Patients Experience: Session-by-Session Timeline

  • Sessions 1–2: warmth and mild relaxation in treated area; occasional transient increase in awareness of the region (expected, not adverse)
  • Sessions 3–4: initial reduction in axial (back/neck) pain component; radicular pain component may begin to diminish
  • Sessions 5–8: measurable VAS reduction; improved sleep quality; reduced analgesic use
  • Sessions 9–12: functional gains — improved walking tolerance (lumbar), improved grip and reach (cervical); SSEP normalization in responsive patients

Comparison with Standard Disc Herniation Treatments

Treatment Pain Reduction Neurological Recovery Risk Profile Philippines Availability
PEMF (clinical grade) Significant (VAS p=0.024); 36% vs 10% in LBP RCT SSEP latency normalization p=0.016–0.022 Very low; narrow contraindications Growing — 70+ IL clinics; PH expansion phase
NSAIDs Moderate short-term None GI bleed, renal, cardiovascular Universal — OTC and Rx
Epidural steroid injection Strong short-term (6–12 weeks) Partial, variable Infection, dural puncture, steroid side-effects Hospital/pain clinic only
Physiotherapy alone 10% (PMC11914662 control arm) Limited for radiculopathy Minimal Wide
Discectomy surgery 80–90% short-term; recurrence risk Good for motor deficit Surgical, anaesthetic, adjacent segment disease Hospital; ₱150K–₱400K+ cost

Contraindications

  • Active cardiac pacemaker or implanted electronic stimulator
  • Pregnancy
  • Active epilepsy
  • Active malignancy in or adjacent to treatment area
  • Cauda equina syndrome or Grade IV sequestration with motor deficit — surgical referral mandatory before PEMF

Philippine Market Context

Disc herniation is a high-volume presentation in Philippine pain and rehabilitation clinics. The BPO sector alone — 1.5 million workers, predominantly seated — represents an elevated-risk population for L4–L5 and C5–C6 disc pathology. Typical session pricing: ₱1,500–₱2,500 per PEMF session. A standard 10-session disc herniation course generates ₱15,000–₱25,000 in revenue per patient at margins not achievable with physiotherapy alone.

Clinics offering PEMF + manual therapy + neural mobilization as an integrated disc herniation programme report faster patient throughput, higher completion rates, and stronger referral networks from orthopedic surgeons seeking non-surgical alternatives for Grade I–II presentations.

Frequently Asked Questions

How does PEMF compare to traction for disc herniation?

Mechanical traction reduces intradiscal pressure mechanically; PEMF works at the cellular and neurochemical level. The modalities are complementary — PEMF before traction reduces periradicular inflammation, making the disc more responsive to mechanical deloading. Many 70+ Israeli clinics (population: 9M) now expanding to the Philippines use a sequenced approach: PEMF → traction → manual therapy.

Can PEMF be used with a herniated disc while awaiting surgery?

Yes, for Grade I–III presentations without red flags. PEMF can provide meaningful pain relief and functional improvement during the waiting period, and in some cases clinical improvement sufficient to defer surgery. Clear communication with the referring orthopedic surgeon is essential.

What is the recurrence rate after PEMF treatment?

PEMF addresses both the inflammatory pain component and, via SIRT1-autophagy pathways, the underlying disc biology. However, without ergonomic modification and core stabilization exercise, mechanical recurrence risk remains. Clinics combining PEMF with exercise rehabilitation report lower recurrence rates than PEMF alone.

Does PEMF work for chronic disc herniation (symptoms > 6 months)?

The evidence supports PEMF for both acute and chronic radiculopathy. The 2025 systematic review (PMC11775040, 9 RCTs, n=420) showed significant benefit for chronic low back pain with radicular component. Chronic presentations may require 12–16 sessions before maximum benefit is reached.

PainFree Philippines is expanding clinical PEMF services across the archipelago. Request the full investor and clinic operator brief — covering device specifications, revenue modelling, and the complete evidence dossier.

Request Investment Brief →